Studies on the antiphlogistic activity of cytostatics.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000963:Antimetabolites / Q000494:pharmacology* / Q000627:therapeutic use; D002351:Carrageenan; D002701:Chloramphenicol / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D003911:Dextrans; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005472:Fluorouracil / Q000494:pharmacology; D005528:Foot; D006868:Hydrolysis; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy; D007958:Leukocyte Count; D008297:Male; D008727:Methotrexate / Q000494:pharmacology; D010396:Penicillamine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D014228:Triaziquone / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D003911:Dextrans; D002701:Chloramphenicol; D003520:Cyclophosphamide; D002351:Carrageenan; D014228:Triaziquone; D010653:Phenylbutazone; D010396:Penicillamine; D005472:Fluorouracil; D007213:Indomethacin; D008727:Methotrexate